Treace Medical Concepts, Inc. Retained Earnings
Treace Medical Concepts, Inc. (TMCI) had Retained Earnings of -$282.83 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$282.83M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$266.95M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$248.99M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$239.60M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$282.83M 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$266.95M 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$248.99M 10-Q · filed 2026-08-07 |
| 2025-09-30 | -$239.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$223.31M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$205.91M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$189.99M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$189.49M 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$174.13M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$152.92M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$134.25M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$127.97M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$110.44M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$98.17M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$84.72M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$80.31M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$68.17M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$50.94M 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$41.91M 10-K · filed 2023-03-08 |
| 2021-09-30 | -$35.29M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$28.87M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$23.79M 10-Q · filed 2021-05-25 |
| 2020-12-31 | -$21.35M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |